Peptides for Women: What Users Report
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
Women here mostly write about GLP-1 weight-loss drugs, BPC-157 for injuries, GHK-Cu for skin, and PT-141 for libido. Several report menstrual changes, hair shedding or nausea. Peptides are not approved for menopause symptoms, and research peptides are not studied in pregnancy. See perimenopause and PT-141. This is not a dosing recommendation.
What women report
This topic currently has 31 tagged published confessions. The notes below are individual stories, not rates.
Reports tagged for women cover the same compounds as everyone else, with a few themes of their own. These are single stories. This is not a dosing recommendation.
| Theme | Peptide | Report |
|---|---|---|
| Libido: "PT-141 works on us too" | PT-141 | #117 |
| Fertility: tried during unexplained infertility after IVF | Kisspeptin | #64 |
| Hair loss: a third of density in 5 months | Semaglutide | #43 |
| Skin: face looked younger | GHK-Cu | #75 |
| Weight: 71 lb over 9 months, with A1C and blood pressure changes | Retatrutide | #58 |
| Moles darkened and new ones appeared | Melanotan II | #82 |
Midlife, cycles and sexual health
For menopause-transition searches see peptides for menopause, perimenopause and hot flashes — none of those pages claims a peptide replaces standard care. Libido and arousal stories sit on peptides for libido and sex drive. Metabolic and cycle questions often overlap with PCOS; pelvic pain needs specialist pathways covered under endometriosis (no peptide is approved for it).
Pregnancy, fertility and safety
Fertility stories like #64 involve a specialist; nothing here replaces one. GLP-1 drug labels advise against use in pregnancy, and unapproved peptides have no pregnancy safety data. Related: peptides for weight loss, skin, hair, legal status in Canada.
Related topics
Anonymous reports tagged for women
MT-2 obsessed with the libido bump, but it wrecked my sleep and left me restless half the night.
#111If you are a woman who has used a peptide, submit what happened. Few people write about this honestly.
Submit yourscommunity guides:
More confessions from the archive
Community Q&A
- What peptides do women use?
- In reports tagged for women: GLP-1s for weight (such as #58 on retatrutide), PT-141 for libido (#117), kisspeptin during fertility treatment (#64), and GHK-Cu for skin (#75).
- Are there peptides for menopause or perimenopause?
- Nothing is approved as peptide menopause therapy. See the menopause, perimenopause and hot-flashes topic pages for evidence vs hype.
- Do women report different side effects?
- Hair loss comes up: #43 describes losing a third of their hair density on semaglutide. #82 describes moles darkening on melanotan. These are single stories, not rates.
- Are peptides safe during pregnancy?
- GLP-1 drug labels advise against use in pregnancy, and unapproved peptides have no pregnancy safety data. Talk to your doctor.
- Does this page give dosing advice?
- No. Peptide Confessions does not publish dosing, cycling or sourcing guidance.
- Can women use peptides safely?
- Approved peptide medicines such as semaglutide, tirzepatide and bremelanotide have known safety profiles in women, set out in their labels, and are not recommended in pregnancy. Unapproved compounds have no such data. Women's reports flag hair shedding and cycle changes on GLP-1s, and mole changes on melanotan. Anyone pregnant, trying to conceive or breastfeeding should speak to a clinician before using any peptide.
- What peptides do women use most?
- By account volume: GLP-1s (semaglutide, tirzepatide) for weight loss are the most common in women's accounts. BPC-157 for gut and injury recovery appears frequently. PT-141 for libido is the one peptide category where women's accounts are proportionally dominant. Melanotan II for tanning and melanotan 1 for skin quality appear in women's accounts with consistent use-case differentiation from men's accounts. GH secretagogues (CJC-1295 + ipamorelin) for body composition and sleep appear in women's accounts at rates consistent with the broader community.
- Do peptides affect the menstrual cycle?
- Reports describe cycle changes mainly during rapid weight loss on GLP-1s, usually attributed to the weight loss itself. GLP-1s can also reduce the effectiveness of oral contraceptives (tirzepatide's label specifically warns about this), and fertility can rise as weight falls. GLP-1s are not recommended in pregnancy. A changed cycle is worth raising with a clinician.
- Is PT-141 effective for women?
- Bremelanotide is FDA-approved (Vyleesi) for hypoactive sexual desire disorder in premenopausal women, based on trials showing modest improvement in desire scores. Reports from women describe it as working for some, with nausea the main drawback. It is not approved in Canada. This site does not publish doses; the approved product is used as directed by its label.
- Do women respond differently to peptides?
- Some reports suggest it, but this site does not publish dose comparisons. For prescribed medicines, dose is set by the prescriber and label, not by sex; for unapproved compounds, there is no validated dose to compare. The recurring point in women's reports is more side effects at amounts others describe as fine.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.